The present Flexible Inflation Targeting (FIT) framework in India as a mandate for monetary policy to manage inflation at 4% (+/-) 2% is ending in March 2026 and is under review. In this regard the Reserve Bank of India (RBI) has brought out a well-researched discussion paper, and has several questions for which views have […]
Continue Reading
Indian Hotels Company (IHCL), said it has signed definitive agreements to acquire 51% stake in Sparsh Infratech Private Limited, which owns ‘Atmantan’, a well-established luxury wellness centre located in Mulshi near Pune, for ₹240 crore. “The acquisition gives IHCL ownership of the Atmantan brand and its proprietary expertise, enabling expansion of the wellness platform in […]
Continue Reading
The Securities and Exchange Board of India (SEBI) has proposed to mandate the publication of offer document summary and rationalise disclosures in the document to improve information accessibility, according to a consultation paper. The regulator proposed making the offer document summary available separately from the draft offer document and post it on the websites of […]
Continue Reading
The sharp rise in gold prices and the potential impact of Central Bank Digital Currency (CBDC) on central bank balance sheets are among emerging areas in central bank accounting and disclosures which would gain prominence in coming days said Reserve Bank of India (RBI) Deputy Governor Shishir Chandra Murmu. Stating that the recent sharp rise […]
Continue Reading
A manufacturing facility each of drugmakers Dr. Reddy’s Laboratories and Divi’s Laboratories in Andhra Pradesh and Telangana respectively has concluded inspection by the U.S. Food and Drug Administration (U.S. FDA) without any observations. The active pharmaceutical ingredient (API) facility (CTO-SEZ) of Dr. Reddy’s in Srikakulam was inspected between November 10 and November 14, 2025. It […]
Continue Reading
A formulation manufacturing facility of Aurobindo Pharma subsidiary Eugia Pharma Specialities in Rajasthan has been issued nine observations by the U.S. Food and Drug Administration. The U.S. FDA inspection of the facility, Unit-II in Bhiwadi, Alwar, from November 3-14 concluded with nine observations. They are procedural in nature and will be responded to within the […]
Continue Reading
Generic drugmaker Natco Pharma reported September quarter consolidated net profit declined more than 23% to ₹517.9 crore compared to ₹676.5 crore a year earlier on the back of muted topline growth. Total income increased to ₹1,463 crore (₹1,434.9 crore) buoyed by Other Income of ₹100 crore (₹63.8 crore). Revenue from operations declined to ₹1,363 crore […]
Continue Reading
Image used for representational purposes only. | Photo Credit: Reuters To provide relief to exporters on account of trade disruptions arising due to global headwinds, more specifically tariffs, the Reserve Bank of India (RBI) on Friday (November 14, 2025) announced a host of trade relief measures that could mitigate a part of the impact. It […]
Continue Reading
Union Minister Piyush Goyal exchange handshakes with Canada’s Minister of International Trade Maninder Sidhu during the 7th India-Canada Ministerial Dialogue on Trade and Investment as part of the New Roadmap 2025, in New Delhi on November 13, 2025. Photo: X/@PiyushGoyal via ANI. India and Canada agreed to bolster long-term supply chain partnerships in critical minerals […]
Continue Reading
Image used for representational purposes only. | Photo Credit: Reuters Equity benchmark indices Sensex and Nifty reversed early losses to end modestly higher on Friday (November 14, 2025) as investors turned to buying blue-chip stocks at beaten down prices. The 30-share BSE Sensex benchmark began the trade on a negative note by declining 449.35 points, […]
Continue ReadingCopyright © 2022
Designed and Developed by Cpool Digital Learning
